Understanding Cancer Metabolism: A New Research-Based Approach to Supporting Patients
Join Dr. Robert Hoffman, a renowned cancer researcher, for a live educational webinar exploring the role of methionine dependence in cancer biology and how methioninase supplementation is being studied as a complementary approach alongside standard cancer care.
Built on 50+ years of cancer metabolism research by Dr. Robert Hoffman.
When
Thursday, May 28th
8:00 AM PDT (Los Angeles / Vancouver)
6:00 PM MSK (Moscow Time)
Where
Virtual (Zoom)
Contact
info@anticancerinc.com
Webinar
This webinar will be presented in English and Russian.
Этот вебинар будет проводиться на английском и русском языках.
During this webinar, we’ll discuss:
What cancer metabolism is and why it matters
The concept of methionine dependence in cancer cells
How methioninase works to lower circulating methionine
Published case reports and clinical observations
How this supplement may be used alongside conventional treatment under physician supervision
Questions to discuss with your healthcare team
Who should attend?
Cancer patients exploring research-based complementary approaches
Family members and caregivers
Individuals interested in cancer metabolism research
Healthcare professionals seeking a patient-friendly overview
Interested in learning more about this research and how it may fit into a broader care plan?
Reserve your spot for this educational webinar.
Important Disclaimer
This webinar is intended for educational purposes only. The methioninase product discussed is a nutritional supplement and is not intended to diagnose, treat, cure, or prevent any disease. Patients should consult their treating physician before making any changes to their care plan.
Significance of research
Cancer cells often require unusually high amounts of methionine, an essential amino acid, to grow and divide. Dr. Hoffman’s research has focused on this metabolic vulnerability for more than five decades. Methioninase is a nutritional supplement designed to reduce methionine levels and support metabolic balance while patients continue working with their medical team.
Published case reports
Dr. Hoffman’s research group has published case reports describing encouraging outcomes in patients with advanced cancers, including pancreatic, breast, prostate, rectal cancer, glioma, and chronic lymphocytic leukemia.
These reports describe methioninase supplementation used in combination with standard treatment approaches and low-methionine dietary strategies.
AntiCancer Inc.
EMAIL
info@anticancerinc.com
AntiCancer Inc. © 2025. All rights reserved.